Renouvellance
Commercial- Indications
- Cosmetic
Company intelligence / Profile preview
Microphyt develops natural bioactive ingredients from microalgae using proprietary large-scale biomimetic cultivation technology. Their portfolio targets cognitive health, weight management, active nutrition/recovery, anti-aging, e-sports performance enhancement, and cosmetic applications. Products are commercialized in the nutraceuticals and cosmetics markets. The company has raised over $50M in funding with strategic partnerships including L'Oréal as a minority investor. Their patented CAMARGUE platform enables sustainable industrial-scale production of diverse microalgal species previously considered uncultivable.
4 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Microphyt.